midpage
Projects
Sign in to see your projects.
632 F.Supp.3d 949
E.D. Mo.
2022
Read the full case

Background

  • Plaintiff LifeScience Technologies (LST) develops a virtual care platform called m.Care and claims certain features, source code, interfaces, documentation, and know‑how are trade secrets.
  • In 2015 LST contracted with Mercy under multiple agreements (NDA, SaaS agreement, PMSA) to expand m.Care for Mercy’s use; those agreements allocated certain ownership and confidentiality rights.
  • Around 2018 Mercy engaged Myia Labs to co‑develop a virtual care system; Myia allegedly had no preexisting platform and was given access to Mercy’s m.Care environment.
  • LST alleges Mercy permitted Myia to access, reverse engineer, and copy LST’s confidential m.Care materials without LST’s consent; Mercy later invested in Myia and migrated from m.Care to Myia’s product.
  • LST sued (Counts include breach of contract, DTSA and MUTSA misappropriation, Missouri Computer Tampering Act, unjust enrichment, civil conspiracy, unfair competition, and tortious interference). Mercy and Myia moved to dismiss; the court denied Mercy’s motion and granted Myia’s in part.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Breach of contract (Count I) v. Mercy Mercy violated confidentiality and anti‑reverse‑engineering provisions by granting Myia unauthorized access to LST property Agreements grant Mercy ownership/rights to content and broad rights to use/share with third parties, so no breach Denied Mercy's motion: complaint pleads breach plausibly; contract interpretation is factual for later stages
Trade‑secret misappropriation (Counts II–III) v. Mercy & Myia (DTSA & MUTSA) LST alleges protectable trade secrets (features, source/object code, documentation, logic, know‑how) and that Mercy gave Myia access which Myia used to build a derivative product Defendants say LST failed to identify trade secrets with requisite particularity and Agreements permit access/use Denied: pleading stage allows broad trade‑secret descriptions; specificity disputes are for discovery/summary judgment
Missouri Computer Tampering Act (Count IV) m.Care is LST’s system/data and Mercy/Myia accessed it without authorization to create competing software Defendants argue Mercy’s contractual rights precluded unauthorized access Denied: complaint alleges ownership and unauthorized access sufficient to state MCTA claim
Common‑law claims — unjust enrichment, conspiracy, unfair competition (Counts V–VII) Claims arise from wrongdoing and are pleaded separately from trade‑secret counts Defendants: MUTSA preempts state common‑law claims that are derivative of trade‑secret misappropriation; Myia says unjust enrichment not pleaded against it Preemption inquiry premature; unjust enrichment dismissed as to Myia (benefit flowed to Mercy), otherwise claims survive for now
Tortious interference (Count VIII) v. Myia Myia intentionally induced breach/used improper means to obtain LST materials and interfered with LST–Mercy relationship Myia: no knowledge of contract terms, no improper means, and MUTSA preempts Denied: complaint plausibly pleads Myia’s knowledge, intentional interference, and lack of justification (alleged improper means)
Sufficiency of service on Myia — Myia: complaint exhibits (Agreements) were not attached at service so service defective Denied: attaching exhibits is permissive; exhibits were later provided/redacted and issue is moot
Motion for more definite statement (Mercy) — Mercy: complaint is too vague to respond Denied: complaint intelligible and sufficiently detailed to permit response

Key Cases Cited

  • Ashcroft v. Iqbal, 556 U.S. 662 (2009) (facial plausibility standard for Rule 12(b)(6))
  • Bell Atl. Corp. v. Twombly, 550 U.S. 544 (2007) (pleading must be plausible, not merely conceivable)
  • Scheuer v. Rhodes, 416 U.S. 232 (1974) (liberal acceptance of allegations at pleading stage)
  • Oakwood Lab., LLC v. Thanoo, 999 F.3d 892 (3d Cir. 2021) (trade‑secret plaintiffs face catch‑22 re: specificity; discovery often necessary)
  • Anzaldua v. NE Ambulance & Fire Prot. Dist., 793 F.3d 822 (8th Cir. 2015) (interpretation of Missouri Computer Tampering Act in context of civil claims)
  • Nazeri v. Mo. Valley Coll., 860 S.W.2d 303 (Mo. 1993) (to show absence of justification in tortious interference, plaintiff must show defendant used "improper means")
  • Lyn‑Flex W., Inc. v. Dieckhaus, 24 S.W.3d 693 (Mo. Ct. App. 1999) (existence of trade secret is a question of law based on factual record)
Read the full case

Case Details

Case Name: LifeScience Technologies LLC v. Mercy Health
Court Name: District Court, E.D. Missouri
Date Published: Sep 29, 2022
Citations: 632 F.Supp.3d 949; 4:21-cv-01279
Docket Number: 4:21-cv-01279
Court Abbreviation: E.D. Mo.
Log In